Inaktiver Wert

Algeta ASA Aktie Other OTC

Aktien

Schlusskurs Other OTC Andere Börsenplätze
- ^USD	-

Actavis : Factbox - M&A frenzy transforming global pharma	06.05.14
Actavis : M&A frenzy in healthcare sector	06.05.14
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	24.03.14
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	24.02.14
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19.12.13

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	+20,03 %	126 Mrd.
REGENERON PHARMACEUTICALS, INC.	+23,61 %	118 Mrd.
ARGENX SE	+23,26 %	27,87 Mrd.
BIONTECH SE	-18,07 %	20,95 Mrd.
GENMAB A/S	-15,13 %	16,92 Mrd.
BEIGENE, LTD.	-14,81 %	16,18 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+9,78 %	14,84 Mrd.
WUXI APPTEC CO., LTD.	-46,10 %	14,79 Mrd.
SAREPTA THERAPEUTICS, INC.	+52,34 %	14,08 Mrd.